InvestorsHub Logo
Followers 56
Posts 8435
Boards Moderated 0
Alias Born 05/14/2015

Re: None

Friday, 05/07/2021 4:37:49 PM

Friday, May 07, 2021 4:37:49 PM

Post# of 118363
So Konman Koos can't even afford to put out a PR about the licensing deal today and begged ONPH to foot the bill. Notice that no specifics were mentioned. I wonder why?

On top of that, the news couldn't get the stock to cloase past 2 cents.

The IP is trash as we now just learned that Koos wants to revive the patent(s) he abandoned. If the IP was worth something, someone else would have come on in to grab it and issue their own patent. But no one did because ITS WORTHLESS JUNK!

ONPH is doing Koos a solid and we don't know the reason yet but we can be sure onph will end up doing nothing with the license.

Think about it. If the ip was worth something, Koos would have gone with an actual functional and reputable pharma had that pharma had any interest. No pharma has any interest.

Same situation with Ichim's companies. None of them have any significant deal with any large pharma at the moment.